Levetiracetam solution
Levetiracetam solution is mainly composed of Levetiracetam (HY-B0106). Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent.
For research use only. We do not sell to patients.
- CAS No.: 102767-28-2
- Formula: C8H14N2O2
- Molecular Weight:170.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All DNA Methyltransferase Isoforms
More
Biological Activity
Description
Chemical Information
-
CAS No. 102767-28-2
-
Molecular Weight 170.21
-
Formula C8H14N2O2
-
SMILES
NC([C@H](CC)N1CCCC1=O)=O
-
Synonyms
UCB L059 solution
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Bianca Maria Scicchitano, et al. Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Cancer Cell Int. 2018 Sep 10;18:136. [Content Brief]
[2]. Delia M Talos, et al. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model. Pediatr Res. 2013 Jan;73(1):24-30. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Levetiracetam solution Related Classifications
HY-FLB0106 Related Classifications
Powered by Bioz